Beyond the vagus nerve hype
How real stimulation is already helping patients.
Levels <[email protected]>
Share
Levels promotes a discussion on the vagus nerve and its potential to treat chronic conditions without drugs. The company highlights a recent conversation with Dr. Kevin Tracey, who explains the science behind vagus nerve stimulation and its limitations. Levels shares key takeaways from the conversation, including the complexity of the vagus nerve and its potential for future treatments.
What the raw message shows
From the headers
- Sent with
-
SendGrid See it in the headers
Across Levels's email
- Sends
- About 3 a week
- DMARC
-
Enforced, reject
Mail failing authentication is refused.
The copy
408 words · about 2 min to read · 2 buttons
How to decide which health advice to trust?
Can we control inflammation before we can measure it?
What if we could treat chronic conditions without drugs? Simply hijacking the body's own signals and tweaking them.
Since July 2025, that's now an option for people with severe rheumatoid arthritis: a pill-size implant stimulates the vagus nerve one minute a day to quiet the condition. The same type of treatment is used for epilepsy, stroke and depression patients, and could move into several more chronic disease. The challenge: We can't yet measure the nerve's signals.
On a recent NextLevel, Dr. Kevin Tracey, who discovered the vagus-inflammation connection 30 years ago, explains why it works, what closing that measurement gap would unlock, and why much of the online conversation is not based on science.
Button The truth about the vagus nerve →
Five Key Takeaways
1. “The vagus nerve” is really about 160,000 fibers.
You have two vagus nerves, each with 80,000 to 100,000 fibers, and every fiber has a specific job and carries signals in only one direction. That’s why Tracey pushes back on advice to stimulate “the” vagus nerve.
2. A small signal can calm inflammation across the body.
One or two thousand fibers reaching the spleen prompt immune cells to make fewer inflammatory molecules, and those cells carry the effect to the joints. In a trial of 242 patients, 53% improved after a year of stimulation.
3. Without a direct readout, predicting response is hard.
Vagus stimulation has been approved for epilepsy and depression for decades, but only about half of patients benefit, and no one can tell in advance which half. Measuring the relevant fibers is the likeliest way to change that.
4. Mapping the nerve could lead to many more treatments.
The first detailed maps of the human vagus nerve are emerging, the first key step toward theoretical fiber-targeted therapies for diabetes, fatty liver disease, and the gut, plus early warning signs of autoimmune disease.
5. Common health proxies capture only a slice.
Tracey says CRP rises with too many things to be a reliable inflammation test, and heart rate variability is noisy and algorithm-dependent. His pick for vagal tone is resting heart rate, though even that reflects only the fibers that slow the heart.
Button Read the full article →
Looking to understand more about your metabolic health?
Explore our health news and advice site, Metabolic Insights
228 Park Ave South, PMB 63877, New York, NY 10003
The words as text: what a screen reader can follow, and all there is when images don't load.
What the headers say
Read from the message's own headers, as it arrived.
- Came from
-
o32.sg.m.dripemail2.com
· 168.245.74.76
SendGrid's sending servers
- SPF
- Pass for drip.levels.com
- DKIM
-
- Pass signed by levels.com
- DMARC
-
Pass for levels.com
Policy: reject
- Unsubscribe
-
One-click
Meets the Gmail and Yahoo rule for bulk senders.
- Complaints
- No feedback-loop header
Show all 17 headers Hide the headers
As received, minus the delivery side: the archive's own addresses show as [recipient], its mail servers as [receiver], signatures are left out and unsubscribe links trimmed to their host.
Route
- Received
- from o32.sg.m.dripemail2.com (168.245.74.76) by [receiver] (cloudflare) id Nlqb0OW8F3tz for <[recipient]>; Thu, 15 Oct 2026 16:00:23 +0000
- Received
- by recvd-c5ccbc74f-cfvj4 with SMTP id recvd-c5ccbc74f-cfvj4-1-6AD0F27C-5 2026-10-15 15:34:20.012955811 +0000 UTC m=+1377189.005354310
- Received
- from MTMxMTA3NDc (unknown) by geopod-ismtpd-50 (SG) with HTTP id Lrew2uosTEu4RD4P3TONiA Thu, 15 Oct 2026 15:34:20.002 +0000 (UTC)
Authentication
- Received-SPF Authentication result
- pass ([receiver]: domain of [recipient]@drip.levels.com designates 168.245.74.76 as permitted sender) receiver=[receiver]; client-ip=168.245.74.76; envelope-from="[recipient]@drip.levels.com"; helo=o32.sg.m.dripemail2.com;
- Authentication-Results Authentication result
- [receiver]; dkim=pass header.d=levels.com header.s=s1 header.b=YhF+HtIx; dmarc=pass header.from=levels.com policy.dmarc=reject; spf=none ([receiver]: no SPF records found for [email protected]) smtp.helo=o32.sg.m.dripemail2.com; spf=pass ([receiver]: domain of [recipient]@drip.levels.com designates 168.245.74.76 as permitted sender) smtp.mailfrom=[recipient]@drip.levels.com; arc=none smtp.remote-ip=168.245.74.76
Platform
- X-Drip-SendingAccount
- 4080355
- X-SG-EID Identifies SendGrid
- u001.79kJZC85z/WE9t9nOmpiHosf7qU1Au+mrKy3jytIn8sMbSWRTgBdv9q1OykY6JKWPKDZiQ4rfqrc7s7sBVdoFFER84tTjnA4IVEz946EQGgQQGNuSvz+BeeUQ1fYoJi+epdvRwjbB0hOOm9AIAysXbI3OUqV+l/mcnoEXFh2esVPQUQeBdhEFPRcU5jf6lwjcBx1AtV1DAQJXL/2u6vsGX3uxRfIAgQhI4YuQduvfIo=
- X-SG-ID Identifies SendGrid
- u001.SdBcvi+Evd/bQef8eZF3BpTL9BgbK5wfSJMJGMsmprCAf2TSkkcsbWsXt+6pnbIhH8M9BPJS4036yhLoCeQ62OASdqPVmzM7Y9BcmjUruPOxodOD2Kw83D+g1zmlcy4Wj8lVKCI2AtCyqqRw5O4csfp2xGNijpPrxdozBcjTwiTcjqPE121bC0DTfXuTQqPPvZ+tMqx/ujvmiwFuN8l0RYk/TEr2L7JkcL4ByoSRPZLpXlolJytMFmekUZVdO1pVjwphmzrhPoJKWzkX789u0FwlWlzPkxPCriuE2AbJ+81tl4kGGBWdYjXcLvggG3uSpDLYqkb1N++6zuRj1HkeM+A9vBBEkhY8pzVJpyMLDN+JUvenkKO+SypKYmnW6z1jvGVdMi5+4FpQFOOhP61cbpB3CC0X4aM0gHZwGq8pBYjLov00kf99/VAb0K9jSNgbqLN67IxEJHHECuUZjKPRyyuP/zBCOnlIc3TYgJCCR3aYJP1a+fXYMHrquXv7SRPPf1MLaaWc0zvexnzGucX1Kxo3Ji4Cl2qnIrIobcQGdCZePvLfMh1117LMeAIgPevDdkoEPA+0tbKbVyR5juHr8TiU2A/n0gVsOB6kt8I4Wlw8AIZqZHq4zT+Xpr67KStUj2QR/+7MeqV3h16e0jZcDetiBlYZ0xsEpK8OYUr6IxA=
- X-Entity-ID
- u001.dEl2Z4sQ4dqI57TjhSSBBA==
Unsubscribe and feedback
- List-Unsubscribe
- <mailto:…@unsubscribe.dripemail3.com>, <https://unsubscribe.dripemail3.com/…>
- List-Unsubscribe-Post
- List-Unsubscribe=One-Click
Message
- Content-Type
- multipart/alternative; boundary=04fe8ea27ae686ea1586a0e9d47df425795339b036732299cd4ede857f1e
- Date
- Thu, 15 Oct 2026 16:00:00 +0000 (UTC)
- From
- Levels <[email protected]>
- Mime-Version
- 1.0
- Message-ID
- <Lrew2uosTEu4RD4P3TONiA@geopod-ismtpd-50>
- Subject
- Beyond the vagus nerve hype
More from Levels
All 25 emailsSimilar campaigns from other brands
Different brands running the same play. Compare any of them side by side.
Archived for reference and commentary. Levels, its logos and content are the property of their respective owners; Inbox Archive claims no affiliation and has disabled all links. If you own this content and would like it removed, get in touch.